Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of genotypic resistance testing on physician selection of antiretroviral therapy.

Journal of human virology - 1 Jan 2000

Jones S, Klotman M E

Abstract excerpt

OBJECTIVES: To determine the impact of genotypic resistance testing on physician selection of antiretroviral therapy. STUDY DESIGN/METHODS: This was a prospective, observational study. A single genotypic resistance test was done when patients failed highly active antiretroviral therapy. The antiretroviral regimen predicted at the time the genotypic resistance assay was done was compared with the regimen that was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Practice Patterns, Physicians'

Share to Treatment Failure

Source

Identifiers

PMID: 11694849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of genotypic resistance testing on physician selection of antiretroviral therapy.PMID 11694849Read ↗

The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection.Semantic proximity Read ↗

Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.Semantic proximity Read ↗

HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?Semantic proximity Read ↗

Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006.Semantic proximity Read ↗

HIV-1 resistance testing influences treatment decision-making.Semantic proximity Read ↗

How does expert advice impact genotypic resistance testing in clinical practice?Semantic proximity Read ↗

How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.Semantic proximity Read ↗

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.Semantic proximity Read ↗

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.Semantic proximity Read ↗

Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen).Semantic proximity Read ↗

A randomized controlled trial of the clinical utility of genotypic resistance testing in patients with limited prior exposure to antiretroviral drugs.Semantic proximity Read ↗

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.